Innovive Pharmaceuticals Inc.'s managers have strong backgrounds in cancer, which they are leveraging collectively to seek early-stage drug candidates for speedy development and marketing. The firm looks for high-value compounds that can be differentiated from others already on the market and guided quickly through development. Innovive presently has three potential cancer treatments in its pipeline.

Each month, Start-Up presents a survey of technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.

Summarizing the month in European dealmaking.